Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Rivaroxaban (Xarelto) Effective for Atrial Fibrillation Patients with High Stroke Risk

Posted Sep 06 2011 8:24am

Just ahead of the FDA Advisory Committee hearing on rivaroxaban for stroke prevention in atrial fibrillation, we report in more depth on the ROCKET-AF trial results published recently in the New England Journal of Medicine. Rivaroxaban was shown to be as effective as warfarin (Coumadin) for stroke prevention in a high-risk afib population. To learn more, see:

Rivaroxaban as Effective as Warfarin for Stroke Prevention in Atrial Fibrillation

Post a comment
Write a comment: